Psychemedics Corp.
(NASDAQ : PMD)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Servicestothe Health Industry
symbolcompany%chnglast%shortavg$volume
IQVIQVIA Holdings, Inc. 1.98%234.210.0%$265.11m
DGXQuest Diagnostics, Inc. -1.56%135.324.4%$169.13m
LHLaboratory Corp. of America Holdings -0.56%275.022.3%$155.43m
PLXProtalix Biotherapeutics, Inc. -4.70%2.7418.6%$6.74m
NOTVInotiv, Inc. 1.98%23.140.0%$3.36m
AMEHApollo Medical Holdings, Inc. -1.03%30.900.0%$3.08m
NRCNational Research Corp. -0.47%49.060.0%$1.60m
PMDPsychemedics Corp. 2.29%6.700.7%$0.09m
ATHNathenahealth, Inc. 0.21%9.7617.4%$0.06m

Company Profile

Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. It specializes in a five panel drug testing process for cocaine, opioids, Phenyclidine, amphetamines, and marijuana. It offers workplace, school, and personal drug testing services. The company was founded by Werner Baumgartner and Annette Baumgartner on September 24, 1986 and is headquartered in Acton, MA.